Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Atkins

Showing results (211-220 of 493) with videos related to

Pageof 50
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2010
The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinomaDaniel C Cho, Matthew B Cohen, David J Panka, et al.
Melanoma Research|May 5, 2011
Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanomaErin R DeRose, Alexander Pleet, Wei Wang, et al.
Anti-Cancer Drugs|April 22, 1999
Conventional dose melphalan is inactive in metastatic melanoma: results of an Eastern Cooperative Oncology Group Study (E1687)H Hochster, M H Strawderman, J E Harris, et al.
Cancer|March 28, 2006
Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacyKen Wyman, Michael B Atkins, Victor Prieto, et al.
Melanoma Research|December 2, 2021
Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitorsCharlene M Mantia, Lillian Werner, Brian Stwalley, et al.
Clinical Genitourinary Cancer|October 23, 2013
Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinomaPeter Beddy, Elizabeth M Genega, Long Ngo, et al.
The Oncologist|November 11, 2023
A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell CarcinomaRana R McKay, Katharina Leucht, Wanling Xie, et al.
Alcoholism, Clinical and Experimental Research|October 6, 1997
Ethanol-induced changes in prostaglandin E concentration in the intact cerebral cortex of preterm and near-term fetal sheepJ D Reynolds, D H Penning, K A Kimura, et al.
Nuclear Medicine Communications|October 1, 1996
Frequency of extra-cardiac activity and its effect on 99Tcm-MIBI cardiac SPET interpretationP K Rehm, F B Atkins, H A Ziessman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 21, 2007
Preserved expression of GLUT4 prevents enhanced agonist-induced vascular reactivity and MYPT1 phosphorylation in hypertensive mouse aortaKevin B Atkins, Antoine Prezkop, James L Park, et al.
Pageof 50

Showing results (211-220 of 493) with videos related to

Sort By:
Pageof 50
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2010
The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinomaDaniel C Cho, Matthew B Cohen, David J Panka, et al.
Melanoma Research|May 5, 2011
Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanomaErin R DeRose, Alexander Pleet, Wei Wang, et al.
Anti-Cancer Drugs|April 22, 1999
Conventional dose melphalan is inactive in metastatic melanoma: results of an Eastern Cooperative Oncology Group Study (E1687)H Hochster, M H Strawderman, J E Harris, et al.
Cancer|March 28, 2006
Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacyKen Wyman, Michael B Atkins, Victor Prieto, et al.
Melanoma Research|December 2, 2021
Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitorsCharlene M Mantia, Lillian Werner, Brian Stwalley, et al.
Clinical Genitourinary Cancer|October 23, 2013
Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinomaPeter Beddy, Elizabeth M Genega, Long Ngo, et al.
The Oncologist|November 11, 2023
A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell CarcinomaRana R McKay, Katharina Leucht, Wanling Xie, et al.
Alcoholism, Clinical and Experimental Research|October 6, 1997
Ethanol-induced changes in prostaglandin E concentration in the intact cerebral cortex of preterm and near-term fetal sheepJ D Reynolds, D H Penning, K A Kimura, et al.
Nuclear Medicine Communications|October 1, 1996
Frequency of extra-cardiac activity and its effect on 99Tcm-MIBI cardiac SPET interpretationP K Rehm, F B Atkins, H A Ziessman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 21, 2007
Preserved expression of GLUT4 prevents enhanced agonist-induced vascular reactivity and MYPT1 phosphorylation in hypertensive mouse aortaKevin B Atkins, Antoine Prezkop, James L Park, et al.
Pageof 50